(Q46670294)
Statements
Osteoprotegerin is associated with silent coronary artery disease in high-risk but asymptomatic type 2 diabetic patients (English)
Antoine Avignon
Ariane Sultan
Stéphane Elaerts
Jean Paul Cristol
1 September 2005